Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
Who should care: General readers · AI governance · Policy
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.